Post Profile






Botox maker Allergan just struck another billion-dollar deal (AGN, TBRA)

Allergan, the drugmaker behind Botox, is on a shopping spree. The company on Monday said it's acquiring the rights to a drug to treat Crohn's Disease and ulcerative colitis for as much as $1.27 billion. The drug is still in development, so Allergan is only paying $250 million now, but it'll owe AstraZeneca more as it hits certain milestones. With this deal, Allergan has committed $3.
read more

share

Related Posts


2 studies identify potential new drug for Crohn's disease and ulcerative colitis

Academics / General Science : Science Codex

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The fin...

AbbVie's New Crohn's Disease Drug Candidate

Business & Finance / Personal Finance : Savings Experiment

AbbVie's drug Humira is currently the best-selling medication on the planet, and it is approved to treat a wide range of diseases, including Crohn's Disease and ulcerative colitis. Recently, the company announced a partnership with ...

Despite Lack Of New Treatment Options, Network Approach Improves Outcomes In Crohn's Disease And Ulcerative Colitis

Health : Medical News Today

Many children with Crohn's disease and ulcerative colitis who received treatment through ImproveCareNow, a national quality improvement and research network, ceased to have symptoms and no longer needed to take steroids for disease ...

Network Approach Improves Outcomes in Crohn's Disease and Ulcerative Colitis Despite Lack of New Treatment Options

Health : Newswise Medical News

Many children with Crohn's disease and ulcerative colitis who received treatment through ImproveCareNow, a national quality improvement and research network, ceased to have symptoms and no longer needed to take steroids for disease ...

23andMe Announces Agreement with Pfizer Inc. to Research Genetics of Ulcerative Colitis and Crohn's Disease

Health : Newswise Medical News

23andMe and Pfizer Inc. announce a new research collaboration to study Inflammatory Bowel Disease (IBD) in a nationwide initiative designed to recruit and genotype individuals who have Crohn's disease or ulcerative colitis.

Comments


Copyright © 2016 Regator, LLC